In contrast, our study reveals that elder extracts did not increase expression of SREBP1 and FASN in hepatic cells, indicating no safety concerns regarding the development of NAFLD if elder extracts are intended to be used to ameliorate atherosclerosis. Here, SREBF1 is linked to metabolic dysfunction-associated steatotic liver disease.